ImmuneOnco Biopharmaceuticals’ HK$319 Million IPO

Pietro Martinoia
Tagged:

Cooley and JunHe advised ImmuneOnco Biopharmaceuticals on the offering, and Kirkland & Ellis and Jingtian & Gongcheng advised the joint sponsors and underwriters.ImmuneOnco Biopharmaceuticals announced its…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

…

This content is for Standard 1 Year members only.
Login Join Now